Stay updated on Arginase Inhibitor & Checkpoint Therapy in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Arginase Inhibitor & Checkpoint Therapy in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Arginase Inhibitor & Checkpoint Therapy in Solid Tumors Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for the completed INCB001158 cancer study is displayed, with detailed study information and supporting documents.
    Difference
    95%
    Check dated 2026-11-09T14:50:47.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0, while the page continued to display a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-02T16:29:00.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    A site-wide NIH announcement banner appears above the ClinicalTrials.gov navigation, describing transition-related terminology updates across NIH content.
    Difference
    1%
    Check dated 2026-10-26T16:31:17.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-19T21:47:52.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1; the study page still displays a 403 error.
    Difference
    0.2%
    Check dated 2026-10-13T04:17:13.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study record content and navigation with an access-restricted message. This blocks users from viewing trial details and related documents.
    Difference
    23%
    Check dated 2026-09-21T22:41:13.000Z thumbnail image

Stay in the know with updates to Arginase Inhibitor & Checkpoint Therapy in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Arginase Inhibitor & Checkpoint Therapy in Solid Tumors Clinical Trial page.